Lytix Biopharma AS Capital Reinvestment Ratio

Latest as of September 2021: 0.00x

Lytix Biopharma AS capital reinvestment ratio. Lytix Biopharma AS (LYTIX) has a Capital Reinvestment Ratio of 0.00x as of September 2021, meaning it reinvests 0% of its operating cash flow (Nkr138.23 Million) in capital expenditures (Nkr35.00K). Check LYTIX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

Nkr138.23 Million

NOK

Capital Expenditures

Nkr35.00K

NOK

Data as of

Sep 2021

Most recent filing

Lytix Biopharma AS Capital Reinvestment Ratio by Year (None–None)

Lytix Biopharma AS capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Lytix Biopharma AS operating cash flow efficiency.

Year	Reinvestment Ratio	Operating CF (NOK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow